This is the first trial to assess the clinical efficacy of a vaccine against Ebola disease from the Sudan species of the virus. It is also the first clinical trial of the vaccine during an outbreak. IAVI, the provider of the vaccine, conducted trials for safety and immunogenicity. https://bit.ly/3WLdFy1